droperidol has been researched along with Cancer of the Uterus in 2 studies
Droperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)
droperidol : An organofluorine compound that is haloperidol in which the hydroxy group has been eliminated with the introduction of a double bond in the piperidine ring, and the 4-chlorophenyl group has been replaced by a benzimidazol-2-on-1-yl group. It is used in the management of chemotherapy-induced nausea and vomiting, and in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To better control both acute and delayed emesis resulting from cisplatin(CDDP)-based chemotherapy for gynecological malignancies, we designed a 'cocktail therapy' (CCT) using granisetron (GRN) in combination with methylprednisolone (MPD) plus droperidol (DRP)." | 9.10 | Combination therapy with granisetron, methylprednisolone and droperidol as an antiemetic prophylaxis in CDDP-induced delayed emesis for gynecologic cancer. ( Fukunaka, N; Ishioka, S; Kobayashi, K; Kudo, R; Minami, M; Nishioka, Y; Sagae, S; Sugimura, M; Terasawa, K, 2003) |
| "To better control both acute and delayed emesis resulting from cisplatin(CDDP)-based chemotherapy for gynecological malignancies, we designed a 'cocktail therapy' (CCT) using granisetron (GRN) in combination with methylprednisolone (MPD) plus droperidol (DRP)." | 5.10 | Combination therapy with granisetron, methylprednisolone and droperidol as an antiemetic prophylaxis in CDDP-induced delayed emesis for gynecologic cancer. ( Fukunaka, N; Ishioka, S; Kobayashi, K; Kudo, R; Minami, M; Nishioka, Y; Sagae, S; Sugimura, M; Terasawa, K, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagae, S | 2 |
| Ishioka, S | 1 |
| Fukunaka, N | 2 |
| Terasawa, K | 2 |
| Kobayashi, K | 1 |
| Sugimura, M | 2 |
| Nishioka, Y | 1 |
| Kudo, R | 2 |
| Minami, M | 1 |
| Wataba, K | 1 |
| Akutagawa, N | 1 |
| Hayashi, T | 1 |
| Yamana, K | 1 |
| Nakamura, T | 1 |
| Mizumoto, H | 1 |
| Kitajima, Y | 1 |
2 trials available for droperidol and Cancer of the Uterus
| Article | Year |
|---|---|
Combination therapy with granisetron, methylprednisolone and droperidol as an antiemetic prophylaxis in CDDP-induced delayed emesis for gynecologic cancer.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Droperidol; Drug Therapy, Combina | 2003 |
[A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cro | 1997 |